Steering the FDA back to a place of regulatory steadiness and certainty won’t be easy, Bloomberg Opinion columnist Lisa Jarvis writes.

In an ideal world, this week’s resignation of Food and Drug Administration Commissioner Marty Makary would signal the end of a troubling period at the agency — one where the job of overseeing a ...

A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.  | With the ink barely dry on outgoing commissioner Marty ...

As Donald Trump leaves Beijing after meeting Xi Jinping, how much did this diplomacy accomplish? Plus, does Dr. Marty ...

During a tumultuous 13-month tenure at the FDA, Makary pursued a wide range of ambitious initiatives. Going forward, their status under the next commissioner is unclear.

Makary's tenure at the agency was marked by a series of controversies and clashes.

Marty Makary’s resignation from the Food and Drug Administration (FDA) may help release some pressure by removing one of the ...

The agency’s top food official will step in to the role after Dr. Makary privately said he opposed the administration ...

President Trump announced on Tuesday that Marty Makary has resigned as the embattled commissioner of the Food and Drug ...

FDA Commissioner Marty Makary resigned his position, stepping aside amid a swirl of reports that his tenure was coming to an ...